Article
Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment.
Journal of translational medicine - 4 Oct 2024
Li Xiaodi, Xu Ling, Lu Lianfeng, Liu Xiaosheng, Yang Yang, Wu Yuanni, Zhu Ting, Li Xiaoxia, Li Yanling, Song Xiaojing, Han Yang, Lyu Wei, Cao Wei, Li Taisheng
Abstract excerpt
BACKGROUND: Several studies have reported that combination antiretroviral therapy (cART) enhances the hepatitis B surface antigen (HBsAg) clearance rate in Human Immunodeficiency Virus-1/Hepatitis B Virus (HIV/HBV) coinfected patients, yet the associated immunological characteristics remain unclear. METHODS: Global and specific immune phenotypic profiles were examined in 48 patients with HIV/HBV coinfection...
Topics
- Humans
- HIV Infections
- Hepatitis B Surface Antigens
- Male
- Coinfection
- Female
- Adult
- Hepatitis B
- Middle Aged
- T-Lymphocytes